Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Pentheroudakis, G., Batistatou A., Kalogeras K. T., Kronenwett R., Wirtz R. M., Bournakis E., et al. (2011).  Prognostic utility of β-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study.. Breast Cancer Res Treat. 127(1), 179-93.
Pentheroudakis, G., Kostadima L., Dova L., Georgiou I., Tzavaras T., Vartholomatos G., et al. (2010).  A twisted kiss: in vitro and in vivo evidence of genetic variation and suppressed transcription of the metastasis-suppressor gene KiSS1 in early breast cancer.. Neoplasma. 57(1), 47-54.
Pentheroudakis, G., Mavroeidis L., Papadopoulou K., Koliou G-A., Bamia C., Chatzopoulos K., et al. (2019).  Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab.. Clin Colorectal Cancer. 18(4), e370-e384.
Pentheroudakis, G., Raptou G., Kotoula V., Wirtz R. M., Vrettou E., Karavasilis V., et al. (2015).  Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trial.. PLoS One. 10(5), e0124612.
Pentheroudakis, G., Nicolaou I., Kotoula V., Fountzilas E., Markou K., Eleftheraki A. G., et al. (2012).  Prognostic utility of angiogenesis and hypoxia effectors in patients with operable squamous cell cancer of the larynx.. Oral Oncol. 48(8), 709-16.
Pentheroudakis, G., Spector Y., Krikelis D., Kotoula V., Meiri E., Malamou-Mitsi V., et al. (2013).  Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors.. Clin Exp Metastasis. 30(4), 431-9.
Pentheroudakis, G., Kalogeras K. T., Wirtz R. M., Grimani I., Zografos G., Gogas H., et al. (2009).  Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.. Breast Cancer Res Treat. 116(1), 131-43.
Pentheroudakis, G., Kotoula V., Eleftheraki A. G., Tsolaki E., Wirtz R. M., Kalogeras K. T., et al. (2013).  Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG).. PLoS One. 8(7), e70634.
Peperidou, A., Kapoukranidou D., Kontogiorgis C., & Hadjipavlou-Litina D. (2014).  Multitarget molecular hybrids of cinnamic acids.. Molecules. 19(12), 20197-226.
Pepin, S., Dupuy M., Borja-Tabora C. Fay Corazo, Montellano M., Bravo L., Santos J., et al. (2019).  Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres.. Vaccine. 37(13), 1876-1884.
Peppa, V. I., Arsenopoulou Z. V., Zarogiannis S. G., Deligiorgi T., Jagirdar R., Makantasis I., et al. (2014).  VEGF increases the permeability of sheep pleura ex vivo through VEGFR2 stimulation.. Cytokine. 69(2), 284-8.
Perakakis, N., Polyzos S. A., Yazdani A., Sala-Vila A., Kountouras J., Anastasilakis A. D., et al. (2019).  Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: a proof of concept study.. Metabolism. 154005.
Perdikouri, E. Isidora A., Arvaniti K., Lathyris D., Kiouti F. Apostolido, Siskou E., Haidich A. Bettina, et al. (2019).  Infections Due to Multidrug-Resistant Bacteria in Oncological Patients: Insights from a Five-Year Epidemiological and Clinical Analysis.. Microorganisms. 7(9), 
Pereira, J. B., Cavallin L., Spulber G., Aguilar C., Mecocci P., Vellas B., et al. (2014).  Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs.. J Intern Med. 275(3), 317-30.
Pereira, J. B., Mijalkov M., Kakaei E., Mecocci P., Vellas B., Tsolaki M., et al. (2016).  Disrupted Network Topology in Patients with Stable and Progressive Mild Cognitive Impairment and Alzheimer's Disease.. Cereb Cortex. 26(8), 3476-3493.
Pérez-Nadales, E., Gutiérrez-Gutiérrez B., Natera A. M., Abdala E., Magalhães M. Reina, Mularoni A., et al. (2019).  Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: The impact of cytomegalovirus disease and lymphopenia.. Am J Transplant.
Perifanis, V., Diamantidis M. D., Chalvatzi K., Kaloutsi V., Markala D., Voulgaridou V., et al. (2014).  Concurrent presentation of nodal myeloid sarcoma and bone marrow chronic lymphocytic leukemia/small lymphocytic lymphoma: a unique association.. Int J Hematol. 99(4), 508-12.
Perin, J., Zaric B., Đođić J. Eremić, Potić Z., Potić M., Sekeruš V., et al. (2018).  The cost of hospital treatment of advanced stage lung cancer patients in a developing South East European country.. J Cancer. 9(17), 3038-3045.
Peris, K., Fargnoli M. C., Garbe C., Kaufmann R., Bastholt L., Seguin N. B., et al. (2020).  Comment on 'Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines'.. Eur J Cancer. 131, 100-103.
Peris, K., Fargnoli M. C., Garbe C., Kaufmann R., Bastholt L., Seguin N. B., et al. (2020).  Response to: Comment on 'Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines'.. Eur J Cancer. 140, 154-157.
Peris, K., Fargnoli M. Concetta, Garbe C., Kaufmann R., Bastholt L., Seguin N. Basset, et al. (2019).  Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines.. Eur J Cancer. 118, 10-34.
Perivoliotis, K., Spyridakis M., Zintzaras E., Arnaoutoglou E., Pramateftakis M. G., & Tepetes K. (2019).  An enhanced outpatient modality for the treatment of hemorrhoidal disease: preliminary results.. G Chir. 40(2), 153-157.
Perivoliotis, K., Spyridakis M., Zintzaras E., Arnaoutoglou E., Pramateftakis M-G., & Tepetes K. (2020).  Non-Doppler hemorrhoidal artery ligation and hemorrhoidopexy combined with pudendal nerve block for the treatment of hemorrhoidal disease: a non-inferiority randomized controlled trial.. Int J Colorectal Dis.
Peroulis, N., Kourounakis A. P., Yiangou M., Paramythiotis D., Kotzampassi K., & Hadjipetrou L. (2006).  Effects of the novel non-steroidal anti-inflammatory compound [N-(2-thiolethyl)-2- {2- [N'- (2,6- dichlorophenyl) amino] phenyl}acetamide on cytokines and apoptosis in ischaemic rat brain.. Arzneimittelforschung. 56(10), 688-94.
Perrault, I., Hanein S., Gerard X., Delphin N., Fares-Taie L., Gerber S., et al. (2010).  Spectrum of SPATA7 mutations in Leber congenital amaurosis and delineation of the associated phenotype.. Hum Mutat. 31(3), E1241-50.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές